PCR kit «ROSSAmed HPV screen»
Specifications:
– has high sensitivity and specificity of more than 98%
-the ability to determine HPV simultaneously in one reaction mixture in a test tube
– the kit has been tested on international panels to control the quality of reagent kits
– no risk of false positive results due to the presence of UDG and dUTP enzymes in the reagents
– low risk of cross-contamination due to fewer operations
– ease of use of the kits in work
– adaptation to the main amplifiers – DT, DNA Technology; qTOWER³, Analytik Jena; CFX96, Bio-Rad; Rotor-Gene, Qiagen, Gentier Tianlong, etc.
– average analysis time taking into account the extraction stage: 90 minutes
– number of reactions – 100
– availability of certificates for compliance with international standards ISO 9001:2015 and ISO 13485:2016
Scientific and practical conference dedicated to AIDS Day
On December 1, 2023, in the city of Tashkent, at the Central Hospital under the Ministry of Defense of the Republic of Uzbekistan, a scientific and practical conference dedicated to AIDS Day was held.
The purpose of the conference was to exchange experience in the treatment and diagnosis of the disease.
The ROSSA company took an active part in organizing this event. Tursunova K.Zh. made a report on ROSSA products that are used for HIV diagnostics at the conference. (Commercial Director of ROSSA LLC).
Second Eurasian Forum on the diagnosis and treatment of orphan diseases: “Commonwealth without borders”
On October 24-26, 2023, in the city of Tashkent (Republic of Uzbekistan) – International Hotel Tashkent the Second Eurasian Forum on the diagnosis and treatment of orphan diseases: “Commonwealth without borders” was held.
With the constant development of medical science and technology, there is a growing need to exchange the latest research and experience in the diagnosis, clinical trials and treatment of orphan genetic diseases.
The goal of the forum is to develop international research, scientific, practical and educational projects with the participation of healthcare professionals and scientists from the countries of the Euro-Asian region with the participation of the countries of the EAEU, SCO, ASEAN and BRICS in the interests of patients with orphan genetic diseases.
A community of international experts will discuss the latest developments in the field of genetic medicine, highlight significant research results and identify priorities for further combating orphan diseases.
The ROSSA company took an active part in organizing this Forum in Uzbekistan.
We believe that together we can expand the boundaries of what is possible and make a meaningful contribution to the fight against orphan diseases!